FindTrial
Sign In

beta-glucan

DIETARY_SUPPLEMENT13 trials

Sponsors

Memorial Sloan Kettering Cancer Center, University of Louisville, Kemin Foods LC, Atlas Biomed, Kelly McMasters

Conditions

Autologous Haemopoietic Stem Cell TransplantCardiovascular Risk FactorChemotherapyColdCold SymptomDyslipidemiasFluFlu Symptom

Early Phase 1

Researching Economical Adjuvants to Cancer Therapy
RecruitingNCT07305259
Florida State UniversityHealthy Participants
Start: 2025-11-12End: 2029-09-30Target: 60Updated: 2025-12-26

Phase 1

Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
CompletedNCT00037011
Memorial Sloan Kettering Cancer CenterNeuroblastoma
Start: 2001-11-30Updated: 2013-01-18
Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
TerminatedNCT00087009
Memorial Sloan Kettering Cancer CenterLeukemia, Lymphoma, Lymphoproliferative Disorder
Start: 2004-05-31End: 2008-08-31Updated: 2013-03-19
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
CompletedNCT00492167
Memorial Sloan Kettering Cancer CenterNeuroblastoma
Start: 2005-09-09End: 2022-03-04Updated: 2022-03-07
Beta-glucan and Fatigue in HSCT Survivors
TerminatedNCT05524688
University of FloridaAutologous Haemopoietic Stem Cell Transplant
Start: 2023-02-10End: 2023-08-28Updated: 2023-10-24

Phase 2

Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
CompletedNCT00089258
Memorial Sloan Kettering Cancer CenterNeuroblastoma
Start: 2004-07-31Target: 74Updated: 2013-01-17
Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)
TerminatedNCT00290407
University of LouisvilleLeukemia, Lymphocytic, Chronic, Lymphoma, Small Lymphocytic
Start: 2006-03-31End: 2010-01-31Updated: 2018-05-04
A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers
NCT04710290
E-DA HospitalChemotherapy, Metastatic Cancer
Start: 2018-01-04End: 2021-12-31Target: 90Updated: 2021-01-25
Beta-glucan and Immune Response to Influenza Vaccine
CompletedNCT05074303
University of FloridaHealthy Aging
Start: 2022-07-18End: 2024-08-28Updated: 2025-11-06

Unknown Phase

The Effect of Beta-glucan in Non-Small Cell Lung Cancer
RecruitingNCT00682032
University of LouisvilleNon Small Cell Lung Cancer
Start: 2008-10-31End: 2029-03-31Target: 300Updated: 2025-01-10
Ability of Beta-glucan Supplementation to Augment Immune Function
CompletedNCT03769012
Kemin Foods LCCold, Cold Symptom, Flu +4
Start: 2018-12-27End: 2020-05-30Updated: 2021-02-03
Dietary Fibers Effect on the Gut Microbiota Composition
WithdrawnNCT04114513
Atlas BiomedCardiovascular Risk Factor, Dyslipidemias, Inflammation +2
Start: 2019-11-25End: 2020-09-30Updated: 2021-03-12
Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
RecruitingNCT04513028
Kelly McMastersMelanoma Stage III, Melanoma Stage IV
Start: 2020-11-03End: 2027-01-15Target: 30Updated: 2025-10-30

Related Papers

Yeast Beta-Glucan Enhances Antibody Response Following Influenza Vaccination – A Double-Blind, Randomized, Placebo-Controlled Pilot Trial
Journal of Dietary Supplements2025-07-313 citations
Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma
Cancers2021-12-1415 citations